Salivary Fractalkine Differentiating Periodontitis from Periodontally Healthy Subjects

Table 1

Demographic and clinical periodontal parameters in healthy controls and patients with Stage I, Stage II, and Stage III periodontitis.

	Control		Stage I		Stage II		Stage III
No.	30		30		30		30
	Mean	±SD	Mean	±SD	Mean	±SD	Mean	±SD	p-Value
Age (years)	21.500	2.028	27.955	10.750	34.393	8.829	40.357	8.608	0.067
BMI (kg/cm^2)	23.061	1.798	24.532	2.796	25.750	2.555	24.925	2.606	0.091
BOP (%)	6.350	1.493	30.950	14.525	28.418	11.634	31.418	12.056	0.000
PPD (mm)	2.30	1.020	4.050	0.086	4.243	0.162	4.496	0.342	0.000
CAL (mm)	0.000	0.000	1.759	0.252	3.129	0.556	3.943	0.438	0.000
Gender (N %)
M	15	53.57	14	63.64	21	75.00	23	82.14	0.105
F	13	46.43	8	36.36	7	25.00	5	17.86

All results in Table 1 were obtained from the ANOVA test except for sex which was obtained from the chi-square test. BMI: body mass index; BOP: bleeding on probing; PPD: probing pocket depth; CAL: clinical attachment loss; No.: number of participants; M: male; F: female; SD: standard deviations. Level of significance as not significant , significant at . Value except the sex was in mean ± standard deviations.